Mark J. Dunne

6.1k total citations
119 papers, 4.7k citations indexed

About

Mark J. Dunne is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, Mark J. Dunne has authored 119 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Surgery, 55 papers in Endocrinology, Diabetes and Metabolism and 54 papers in Molecular Biology. Recurrent topics in Mark J. Dunne's work include Pancreatic function and diabetes (55 papers), Hyperglycemia and glycemic control in critically ill and hospitalized patients (49 papers) and Ion channel regulation and function (39 papers). Mark J. Dunne is often cited by papers focused on Pancreatic function and diabetes (55 papers), Hyperglycemia and glycemic control in critically ill and hospitalized patients (49 papers) and Ion channel regulation and function (39 papers). Mark J. Dunne collaborates with scholars based in United Kingdom, United States and France. Mark J. Dunne's co-authors include Ole H. Petersen, Ian Findlay, Ruth M. Shepherd, Karen E. Cosgrove, Keith Lindley, A Aynsley‐Green, Claes B. Wollheim, Indraneel Banerjee, Paul E. Squires and Peter J. Milla and has published in prestigious journals such as New England Journal of Medicine, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Mark J. Dunne

118 papers receiving 4.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark J. Dunne United Kingdom	40	2.6k	1.9k	1.6k	991	706	119	4.7k
Show‐Ling Shyng United States	39	3.8k 1.5×	1.8k 1.0×	1.6k 1.0×	742 0.7×	2.2k 3.1×	87	6.3k
Tadao Shibasaki Japan	29	2.5k 1.0×	2.0k 1.0×	1.4k 0.9×	665 0.7×	342 0.5×	46	4.3k
John P. Clement United States	9	2.5k 1.0×	1.2k 0.6×	779 0.5×	813 0.8×	2.7k 3.9×	10	4.7k
Robert G. Tsushima Canada	30	1.6k 0.6×	875 0.5×	498 0.3×	533 0.5×	128 0.2×	59	2.8k
Robert Gros Canada	37	2.1k 0.8×	607 0.3×	1.0k 0.7×	561 0.6×	209 0.3×	94	4.2k
Oleg G. Chepurny United States	32	2.2k 0.9×	1.4k 0.7×	1.1k 0.7×	694 0.7×	93 0.1×	66	3.4k
Chou-Long Huang United States	46	4.1k 1.6×	485 0.3×	371 0.2×	1.1k 1.1×	437 0.6×	84	6.3k
Erik Gylfe Sweden	48	3.5k 1.4×	4.8k 2.6×	2.3k 1.4×	833 0.8×	145 0.2×	202	6.8k
Rüdiger Göke Germany	40	2.9k 1.1×	2.5k 1.3×	3.6k 2.3×	1.4k 1.4×	107 0.2×	108	6.9k
Coimbatore B. Srikant Canada	38	2.2k 0.8×	862 0.5×	1.3k 0.8×	796 0.8×	143 0.2×	73	4.6k

Countries citing papers authored by Mark J. Dunne

Since Specialization

Citations

This map shows the geographic impact of Mark J. Dunne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark J. Dunne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark J. Dunne more than expected).

Fields of papers citing papers by Mark J. Dunne

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark J. Dunne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark J. Dunne. The network helps show where Mark J. Dunne may publish in the future.

Co-authorship network of co-authors of Mark J. Dunne

This figure shows the co-authorship network connecting the top 25 collaborators of Mark J. Dunne. A scholar is included among the top collaborators of Mark J. Dunne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark J. Dunne. Mark J. Dunne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Humphries, Jonathan D., Jessica Burns, Janet A. Askari, et al.. (2022). Pancreatic ductal adenocarcinoma cells employ integrin α6β4 to form hemidesmosomes and regulate cell proliferation. Matrix Biology. 110. 16–39. 5 indexed citations

Worth, Chris, Mark J. Dunne, Maria Salomon‐Estebanez, et al.. (2022). The hypoglycaemia error grid: A UK-wide consensus on CGM accuracy assessment in hyperinsulinism. Frontiers in Endocrinology. 13. 1016072–1016072. 13 indexed citations

Worth, Chris, Simon Harper, Maria Salomon‐Estebanez, et al.. (2021). Clustering of Hypoglycemia Events in Patients With Hyperinsulinism: Extension of the Digital Phenotype Through Retrospective Data Analysis. Journal of Medical Internet Research. 23(10). e26957–e26957. 14 indexed citations

Yau, Daphne, Klaus Mohnike, Ross Craigie, et al.. (2020). Case report: contradictory genetics and imaging in focal congenital hyperinsulinism reinforces the need for pancreatic biopsy. International Journal of Pediatric Endocrinology. 2020(1). 17–17. 2 indexed citations

Worth, Chris, Daphne Yau, Maria Salomon‐Estebanez, et al.. (2020). Longitudinal Auxological recovery in a cohort of children with Hyperinsulinaemic Hypoglycaemia. Orphanet Journal of Rare Diseases. 15(1). 162–162. 10 indexed citations

Salomon‐Estebanez, Maria, Daphne Yau, Mark J. Dunne, et al.. (2020). Efficacy of Dose-Titrated Glucagon Infusions in the Management of Congenital Hyperinsulinism: A Case Series. Frontiers in Endocrinology. 11. 441–441. 9 indexed citations

Salomon‐Estebanez, Maria, Zainab Mohamed, Maria Michaelidou, et al.. (2017). Vineland adaptive behavior scales to identify neurodevelopmental problems in children with Congenital Hyperinsulinism (CHI). Orphanet Journal of Rare Diseases. 12(1). 96–96. 9 indexed citations

Han, Bing, Melanie Newbould, Gauri Batra, et al.. (2016). Enhanced Islet Cell Nucleomegaly Defines Diffuse Congenital Hyperinsulinism in Infancy but Not Other Forms of the Disease. American Journal of Clinical Pathology. 145(6). 757–768. 32 indexed citations

Skae, Mars, Indraneel Banerjee, Lindsey Rigby, et al.. (2014). Reduced Glycemic Variability in Diazoxide-Responsive Children with Congenital Hyperinsulinism Using Supplemental Omega-3-Polyunsaturated Fatty Acids; A Pilot Trial with MaxEPAR. Frontiers in Endocrinology. 5. 31–31. 9 indexed citations

10.

Padidela, Raja, Ved Bhushan Arya, Virpi V. Smith, et al.. (2014). Insulinoma in childhood: clinical, radiological, molecular and histological aspects of nine patients. European Journal of Endocrinology. 170(5). 741–747. 29 indexed citations

11.

Hussain, Khalid, Karen E. Cosgrove, Ruth M. Shepherd, et al.. (2002). Uncontrolled insulin secretion from a childhood pancreatic beta-cell adenoma is not due to the functional loss of ATP-sensitive potassium channels.. Endocrine Related Cancer. 9(4). 221–226. 5 indexed citations

12.

Macfarlane, Wendy M., Susan C. Campbell, Lucy J. Elrick, et al.. (2000). Glucose Regulates Islet Amyloid Polypeptide Gene Transcription in a PDX1- and Calcium-dependent Manner. Journal of Biological Chemistry. 275(20). 15330–15335. 57 indexed citations

13.

Abernethy, L J, et al.. (1998). Intra-arterial calcium stimulation test in the investigation of hyperinsulinaemic hypoglycaemia. Archives of Disease in Childhood. 78(4). 359–363. 29 indexed citations

14.

Chan, Susan L.F., et al.. (1998). Characterisation of new efaroxan derivatives for use in purification of imidazoline-binding sites. European Journal of Pharmacology. 355(1). 67–76. 22 indexed citations

15.

Dunne, Mark J., Charlotte Kane, Ruth M. Shepherd, et al.. (1997). Familial Persistent Hyperinsulinemic Hypoglycemia of Infancy and Mutations in the Sulfonylurea Receptor. New England Journal of Medicine. 336(10). 703–706. 181 indexed citations

16.

White, M. C., et al.. (1990). Administration of High-Dose Octreotide (Sandostatin) by Continuous Subcutaneous Infusion for the Treatment of Acromegaly. Hormone Research. 33(1). 13–19. 1 indexed citations

17.

Dunne, Mark J., Richard Aspinall, & Ole H. Petersen. (1990). The effects of cromakalim on ATP‐sensitive potassium channels in insulin‐secreting cells. British Journal of Pharmacology. 99(1). 169–175. 47 indexed citations

18.

Dunne, Mark J.. (1989). Protein phosphorylation is required for diazoxide to open ATP‐sensitive potassium channels in insulin (RINm5F) secreting cells. FEBS Letters. 250(2). 262–266. 45 indexed citations

19.

Dunne, Mark J., Ian Findlay, & Ole H. Petersen. (1988). Effects of pyridine nucleotides on the gating of ATP-sensitive potassium channels in insulin-secreting cells. The Journal of Membrane Biology. 102(3). 205–216. 48 indexed citations

20.

Dunne, Mark J., et al.. (1987). Interaction of diazoxide, tolbutamide and ATP4− on nucleotide-dependent K+ channels in an insulin-secreting cell line. The Journal of Membrane Biology. 99(3). 215–224. 123 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact